CBD for fragile x syndrome brain function
Treatments studied
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial studies whether a daily dose of CBD (a non-psychoactive compound from cannabis) affects brain activity in people with Fragile X syndrome, a genetic condition that causes intellectual disability and behavioral challenges. It aims to see if CBD can improve brain function and behavior.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have a confirmed Fragile X syndrome diagnosis (for the treatment group) or be a healthy adult for comparison.
- Age must be between 7 and 55 years for the Fragile X group, or 18 to 55 for the control group.
- For Fragile X participants: IQ must be below 70 and the Aberrant Behavior Checklist score must be above 20.
- If you take psychoactive medications, you must be on fewer than 3 and stable for at least 3 months.
- You must weigh at least 60 kg (about 132 pounds).
- No history of liver problems, and no metal in the head (for brain scans).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if cannabidiol (CBD) can help with anxiety and improve brain function in people with Fragile X syndrome. Participants will receive CBD or a placebo, and may have brain scans (MRI) or magnetic stimulation (TMS) to see how it works.
This trial tests an investigational medicine called MRM-3379 in males with Fragile X syndrome. It looks at how the medicine affects thinking and behavior over time.
This trial tests a new medicine called CTH120 to see if it is safe and helpful for adult men with Fragile X syndrome. You may be able to join if you meet certain health and age requirements.
This study measures how well people with autism or fragile X syndrome perceive speech in noisy settings, compared to typically developing individuals. It uses EEG to understand brain activity during listening tasks.
This study uses safe brain monitoring (fNIRS and EEG) to see how infants with Fragile X syndrome process sounds compared to other infants. The goal is to find early signs of hearing or perception issues.
This trial tests whether special sound patterns played through headphones can help improve thinking and reduce sensitivity to noise in children with Fragile X syndrome or autism. The study uses a short daily listening program over several weeks to see if it makes a difference.
Hear when a new Fragile X Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.